Trait

Cibus Announces New Publication: Industrial Scale Gene Editing in Brassica napus

Retrieved on: 
Thursday, November 30, 2023
Gene editing, Trait, Botany, Regeneration, CBUS, Oleic acid, SAN, Protoplast, Plant, Gene, Breeding, Rapeseed, Growth, Rape, Canadian International Council, Environment, Agriculture

(Link Article: https://www.mdpi.com/2037-0164/14/4/77 )

Key Points: 
  • (Link Article: https://www.mdpi.com/2037-0164/14/4/77 )
    “The ability to scale breeding in a precise and repeatable process is the central breakthrough of our high-speed breeding process, which we refer to as the Trait Machine™ System.
  • Here, we demonstrate two case studies of improving oleic oil content and developing pod shatter reduction in Brassica napus by using gene editing tools on an industrial scale.
  • There are four BnaFAD2 genes involved in oleic oil content and eight BnaSHP genes involved in pod shatter tolerance.
  • In order to develop these two traits, we delivered nuclease ribonucleoproteins with Gene Repair Oligonucleotides (GRONs) into protoplasts, with subsequent regeneration into plants on an industrial scale, which encompassed robust tissue culture protocols, efficient gene editing, robotics sampling, and molecular screening, vigorous plant regeneration, growth, and phenotyping.

Trait Biosciences closes on financing led by BAT's Btomorrow Ventures and Gotham Green Partners and advances commercialization of unique water-soluble cannabinoids

Retrieved on: 
Wednesday, October 11, 2023
Drink, CBD, Multimedia, BAT, Cannabinoid, Mobile phone, Trait

SANTA FE, N.M., Oct. 11, 2023 /PRNewswire/ -- Trait is pleased to announce that it has closed on a funding round led by Btomorrow Ventures (the corporate venture capital arm of BAT) and Gotham Green Partners. Both firms are already significant investors in Trait, and they have been closely involved in the company's development and commercialization efforts.

Key Points: 
  • Both firms are already significant investors in Trait, and they have been closely involved in the company's development and commercialization efforts.
  • Trait Biosciences closes on financing and advances commercialization of unique water-soluble cannabinoids.
  • Hanny Kanafani, President and COO at Trait says: "The collaboration between Btomorrow Ventures and Gotham Green Partners has been a powerful catalyst in advancing Trait's development and commercialization activities.
  • The financing will support Trait's partnerships with contract manufacturers and go-to-market partners, and Trait expects a 1Q 2024 launch of its first-generation water-soluble CBD.

Cibus’ White Mold Resistance Trait in Canola Achieves Another Important Milestone

Retrieved on: 
Wednesday, June 7, 2023
Cell biology, Breeding, Farmer, Gene editing, Disease resistance, Fungal infection, Sclerotinia sclerotiorum, CBUS, SAN, Entrepreneurship, Disease, Agriculture, Sclerotinia, Transition, Trait

This greenhouse tests showed both an enhanced and an additional mode of action from previously reported field trial results of the Cibus Sclerotinia resistance trait.

Key Points: 
  • This greenhouse tests showed both an enhanced and an additional mode of action from previously reported field trial results of the Cibus Sclerotinia resistance trait.
  • Together, these two different modes of action provide an increased level of resistance against Sclerotinia than each alone.
  • “Our exciting new results signal that additional edits can lead to increased levels of Sclerotinia resistance in canola.
  • “Importantly, these new results give us a strong early indication that developing durable resistance using gene editing is commercially relevant and possible.”
    “We have identified multiple modes of action to generate resistance to white mold in canola specifically, and pests and diseases generally.

Louis Moinet Partners with Exclusible and Tafi to Launch Original NFT Collection

Retrieved on: 
Monday, January 10, 2022
People, Benchmark, Exclusively for My Friends, XR, Fashion District, Social media, 3D, Nike, Coca-Cola, ST, Alpha, Space, CSO, Guinness, Trait, Collection, Louis Moinet, Entrepreneurship, Guinness World Records, Benchmark (venture capital firm), Creativity, Partnership, Solution, SALT, CEO, Creative, Technology, Memory, Non-fungible token, Champion, Luxury, Business development, NFT, Mechanical Wonder, Business, SDK, Augmented reality, Mobile phone, Video game console, Entertainment, Metaverse, Tafi

The companies will launch an original NFT collection inspired by the Louis Moinet Space Revolution Watch, the award-winning watch that features spectacular tourbillons, intergalactic spaceships, and extraterrestrial materials.

Key Points: 
  • The companies will launch an original NFT collection inspired by the Louis Moinet Space Revolution Watch, the award-winning watch that features spectacular tourbillons, intergalactic spaceships, and extraterrestrial materials.
  • "With that in mind, we selected the leading creative partners in the NFT space Exclusible and Tafi to launch our inaugural collection of Louis Moinet NFT digital watches.
  • Louis Moinet will also sponsor a celebratory giveaway of some physical Louis Moinet watches to certain NFT holders.
  • Joint holders of Louis Moinet NFTs, Exclusible's Alpha NFT Collection, and Tafi's Non-Fungible People avatar collection will receive additional special benefits.

Trait Biosciences Advances Innovative Water-Soluble Cannabinoid Technology, Delivering Key Milestones in Series A Financing and Appoints Dr. Hanny Kanafani as Vice President

Retrieved on: 
Thursday, December 30, 2021
Champaign County, Illinois, Growth, Nanoparticle, Metabolism, Toxicity, Method, Pillsbury, PepsiCo, Cannabinoid, Solubility, Food science, Laboratory, Research, Doctor of Philosophy, University, Herbalife Nutrition, Technology, Center for Study of Science, Technology and Policy (CSTEP), Drink, Industry, Management, BC, Microbiology, CBD, Trait

"Trait's mission to develop innovative cannabinoid technologies delivering superior water-soluble extracts will enable the formulation of higher quality and safer CBD products."

Key Points: 
  • "Trait's mission to develop innovative cannabinoid technologies delivering superior water-soluble extracts will enable the formulation of higher quality and safer CBD products."
  • "We're proud of the progress our scientists made in advancing our breakthrough technology this past year and excited to have Dr. Hanny Kanafani joining the Trait leadership team.
  • Trait Biosciences Delivers Key Milestones in its earlier C$31Million Series A Financing.
  • Trait Biosciences Inc. is a global leader in cannabinoid research, focused on developing technologies that enable the production of safe, high-quality, predictable, and efficacious CBD products.

Automotive Analytics Startup Trait Signal Announces the Launch of Its Platform, With Private Beta Program Beginning November 15th

Retrieved on: 
Tuesday, November 12, 2019
Data mining, Domain driven data mining, Trait, Software engineering, Computing, Digital technology

LOS ANGELES, Nov. 12, 2019 /PRNewswire/ --Trait Signal announced its entry into the automotive analytics space and its private beta, to begin November 15th.

Key Points: 
  • LOS ANGELES, Nov. 12, 2019 /PRNewswire/ --Trait Signal announced its entry into the automotive analytics space and its private beta, to begin November 15th.
  • The platform structures automotive opinions into actionable insights, and is more accurate, scalable, and affordable than either census data or focus groups.
  • Trait Signal is enrolling customers now for a private beta and will be generally available in January 2020.
  • About Trait Signal: Trait Signal provides accurate opinion data and sentiment analysis to help automotive sales, marketing, and product development leaders build strategies that resonate with car buyers and react to drivers' changing needs.